Pathophysiology and therapeutic management of anemia in gastrointestinal disorders

References

• Camaschella C. Iron deficiency. Blood. 2019;133:30–39.
   PubMed Web of Science ®Google Scholar
• Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133:40–50. .
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Di Sabatino A, Corazza GR. Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders. Br J Haematol. 2018;182:319–329.
   PubMed Web of Science ®Google Scholar
• Elli L, Norsa L, Zullo A, et al. Diagnosis of chronic anaemia in gastrointestinal disorders: a guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP). Dig Liver Dis. 2019;51:471–483.
   PubMedGoogle Scholar
• Hershko C, Hoffbrand AV, Keret D, et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica. 2005;90:585–595.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Comin-Colet J, de Francisco A, et al.; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92:1068–1078.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Lahner E, Bergamaschi G, et al. Cell blood count alterations and patterns of anaemia in autoimmune atrophic gastritis at diagnosis: a multicentre study. J Clin Med. 2019;8:1992.
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Markopoulos K, Albertini R, et al. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica. 2008;93:1785–1791.
   PubMed Web of Science ®Google Scholar
• Kuzminski AM, Del Giacco EJ, Allen RH, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92:1191–1198.
   PubMed Web of Science ®Google Scholar
• Bolaman Z, Kadikoylu G, Yukselen V, et al. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124–3134.
   PubMed Web of Science ®Google Scholar
• Hershko C, Ianculovich M, Souroujon M. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. Acta Haematol. 2007;118:19–26.
   PubMed Web of Science ®Google Scholar
• Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis: pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–541.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Lenti MV, Giuffrida P, et al. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun Rev. 2015;14:1161–1169.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Rugge M, Lahner E, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6:56.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Miceli E, Vanoli A, et al. Time course and risk factors of evolution from potential to overt autoimmune gastritis. Dig Liver Dis. 2022;54:642–644.
   PubMedGoogle Scholar
• Miceli E, Lenti MV, Padula D, et al. Common features of patients with autoimmune atrophic gastritis. Clin Gastroenterol Hepatol. 2012;10:812–814.
   PubMed Web of Science ®Google Scholar
• Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097–1100.
   PubMedGoogle Scholar
• Lahner E, Zagari RM, Zullo A, et al. Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51:1621–1632.
   PubMedGoogle Scholar
• Hershko C, Ronson A. Iron deficiency, Helicobacter infection and gastritis. Acta Haematol. 2009;122:97–102.
   PubMed Web of Science ®Google Scholar
• Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991;101:437–445.
   PubMed Web of Science ®Google Scholar
• Franceschi F, Zuccalà G, Roccarina D, et al. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol. 2014;11:234–242.
   PubMed Web of Science ®Google Scholar
• De Re V, Repetto O, De Zorzi M, et al. Polymorphism in toll-like receptors and Helicobacter pylori motility in autoimmune atrophic gastritis and gastric cancer. Cancers (Basel). 2019;11:648.
   PubMed Web of Science ®Google Scholar
• Parsons BN, Ijaz UZ, D’Amore R, et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 2017;13:e1006653.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Biagi F, Lenzi M, et al. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Dig Liver Dis. 2017;49:947–956.
   PubMedGoogle Scholar
• Toh BH, van Driel Ir, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337:1441–1448.
   PubMed Web of Science ®Google Scholar
• Miceli E, Padula D, Lenti MV, et al. A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study. J Clin Gastroenterol. 2015;49:e1–5. Score models for identifying patients potentially affected by AAG are described.
   PubMed Web of Science ®Google Scholar
• Conti L, Lenti MV, Di Sabatino A, et al. Seronegative autoimmune atrophic gastritis is more common in elderly patients. Dig Liver Dis. 2020;52:1310–1314.
   PubMedGoogle Scholar
• Lenti MV, Miceli E, Cococcia S, et al. Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment Pharmacol Ther. 2019;50:167–175.
   PubMed Web of Science ®Google Scholar
• Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673–1679.
   PubMed Web of Science ®Google Scholar
• Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071–2079.
   PubMed Web of Science ®Google Scholar
• Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.
   PubMed Web of Science ®Google Scholar
• Russell RM, Krasinski SD, Samloff IM, et al. Folic acid malabsorption in atrophic gastritis. Possible compensation by bacterial folate synthesis. Gastroenterology. 1986;91:1476–1482.
   PubMed Web of Science ®Google Scholar
• Zilli A, Cavalcoli F, Ciafardini C, et al. Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: a single-institution observational study. Dig Liver Dis. 2019;51:505–509.
   PubMedGoogle Scholar
• Lenti MV, Savioli J, Achilli G, et al. Autoimmune diseases associated with common variable immune deficiency. Pediatr Allergy Immunol. 2020;26:60–62.
   Google Scholar
• Kalkan Ç, Soykan I. Differences between older and young patients with autoimmune gastritis. Geriatr Gerontol Int. 2017;17:1090–1095.
   PubMed Web of Science ®Google Scholar
• Villanacci V, Casella G, Lanzarotto F, et al. Autoimmune gastritis: relationships with anemia and Helicobacter pylori status. Scand J Gastroenterol. 2017;52:674–677.
   PubMed Web of Science ®Google Scholar
• Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–160.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Cococcia S, Miceli E, et al. Red flags for the diagnosis of autoimmune gastritis. Clin Res Hepatol Gastroenterol. 2022;46:101780.
   PubMed Web of Science ®Google Scholar
• Miceli E, Brondino N, Lenti MV, et al. Impaired quality of life in patients with autoimmune atrophic gastritis. Dig Dis Sci. 2021;66:3322–3329.
   PubMed Web of Science ®Google Scholar
• Cittolin-Santos GF, Khalil S, Bakos JK, et al. Chronic Atrophic gastritis with negative intrinsic factor and parietal cell antibody presenting as a severe hemolytic anemia. Case Rep Hematol. 2020;2020:8697493.
   PubMed Web of Science ®Google Scholar
• Woodford AM, Chaudhry R, Conte GA, et al. Chronic atrophic gastritis presenting as hemolytic anemia due to severe vitamin B12 deficiency. Case Rep Hematol. 2021;2021:9571072.
   PubMed Web of Science ®Google Scholar
• Andrès E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opin Pharmacother. 2010;11:56–249.
   Web of Science ®Google Scholar
• Gaskins AJ, Chiu YH, Williams PL, et al. EARTH Study Team. Association between serum folate and vitamin B-12 and outcomes of assisted reproductive technologies. Am J Clin Nutr. 2015;102:943–950.
   PubMed Web of Science ®Google Scholar
• Lenti MV, Miceli E, Padula D, et al. Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis. Intern Emerg Med. 2018;13:815–816.
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–1194.
   PubMed Web of Science ®Google Scholar
• Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12:561–571.
   PubMed Web of Science ®Google Scholar
• Elli L, Ferretti F, Orlando S, et al. Management of celiac disease in daily clinical practice. Eur J Intern Med. 2019;61:15–24.
   PubMed Web of Science ®Google Scholar
• Corazza GR, Valentini RA, Andreani ML, et al. Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol. 1995;30:153–156.
   PubMed Web of Science ®Google Scholar
• Mahadev S, Laszkowska M, Sundström J, et al. Prevalence of celiac disease in patients with iron deficiency anemia-a systematic review with meta-analysis. Gastroenterology. 2018;155:374–382.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Bai JC, Biagi F. Diagnosis and management of adult coeliac disease: guidelines from the British society of gastroenterology. Gut. 2014;63:1210–1228. .
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill ID, Kelly CP. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.
   PubMed Web of Science ®Google Scholar
• Barisani D, Parafioriti A, Bardella MT, et al. Adaptive changes of duodenal iron transport proteins in celiac disease. Physiol Genomics. 2004;17:316–325.
   PubMed Web of Science ®Google Scholar
• Elli L, Poggiali E, Tomba C. Does TMPRSS6 RS855791 polymorphism contribute to iron deficiency in treated celiac disease? Am J Gastroenterol. 2015;110:200–202.
   PubMed Web of Science ®Google Scholar
• De Falco L, Tortora R, Imperatore N, et al. The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease. Am J Hematol. 2018;93:383–393.
   PubMed Web of Science ®Google Scholar
• Tolone C, Bellini G, Punzo F, et al. The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease. PLoS One. 2017;12:e0185822.
   PubMed Web of Science ®Google Scholar
• Annibale B, Severi C, Chistolini A, et al. Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol. 2001;96:132–137. •Gluten-free diet improves IDA in CeD, but iron stores are still depleted after a one-year follow-up.
   PubMed Web of Science ®Google Scholar
• Thompson T. Folate, iron, and dietary fiber contents of the gluten-free diet. J Am Diet Assoc. 2000;100:1389–1396.
   PubMed Web of Science ®Google Scholar
• Scricciolo A, Elli L, Doneda L, et al. Efficacy of a high-iron dietary intervention in women with celiac disease and iron deficiency without anemia: a clinical trial. Nutrients. 2020;12(17):2122.
   PubMed Web of Science ®Google Scholar
• Elli L, Ferretti F, Branchi F, et al. Sucrosomial iron supplementation in anemic patients with celiac disease not tolerating oral ferrous sulfate: a prospective study. Nutrients. 2018;10:330.
   PubMed Web of Science ®Google Scholar
• Filmann N, Rey J, Schneeweiss S, et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 2014;20:936–45.
   PubMed Web of Science ®Google Scholar
• Bager P, Befrits R, Wikman O, et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol. 2013;48:1286–1293.
   PubMed Web of Science ®Google Scholar
• Rejler M, Tholstrup J, Andersson-Gäre B, et al. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol. 2012;47:937–942.
   PubMed Web of Science ®Google Scholar
• Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47–52.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, McGinley EL, Binion DG, et al. A novel risk score to stratify severity of Crohn’s disease hospitalizations. Am J Gastroenterol. 2010;105:1799–1807.
   PubMed Web of Science ®Google Scholar
• Koutroubakis IE, Ramos-Rivers C, Regueiro M, et al. Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13:1760–1766.
   PubMed Web of Science ®Google Scholar
• Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:250–255.
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Castiglione F, D’Incà R, et al. Prevalence, pathogenesis and management of anemia in inflammatory bowel disease: an IG-IBD multicenter, prospective and observational study [published online ahead of print, 2022 Apr 2]. Inflamm Bowel Dis. 2022; izac054. doi:10.1093/ibd/izac054
   Google Scholar
• D’Silva A, Fox DE, Nasser Y, et al. Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis. Clin Gastroenterol Hepatol. 2021;30(21):S1542–3565.
   Google Scholar
• Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199–205.
   PubMed Web of Science ®Google Scholar
• Guerrero Vinsard D, Karagozian R, Wakefield DB, et al. Maternal outcomes and pregnancy-related complications among hospitalized women with inflammatory bowel disease: report from the National Inpatient Sample. Dig Dis Sci. 2021;10.1007/s10620-021-07210–z.
   PubMed Web of Science ®Google Scholar
• Lomer MC, Kodjabashia K, Hutchinson C, et al. Intake of dietary iron is low in patients with Crohn’s disease: a case-control study. Br J Nutr. 2004;91:141–148.
   PubMed Web of Science ®Google Scholar
• Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599–610.
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Di Sabatino A, Pasini A, et al. Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin. Clin Nutr. 2017;36:1427–1433.
   PubMed Web of Science ®Google Scholar
• Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989;3:1637–1643.
   PubMed Web of Science ®Google Scholar
• Murawska N, Fabisiak A, Fichna J. Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflamm Bowel Dis. 2016;22:1198–1208.
   PubMed Web of Science ®Google Scholar
• Patel D, Trivedi C, Khan N. Management of Anemia in Patients with Inflammatory Bowel Disease (IBD). Curr Treat Options Gastroenterol. 2018;16:112–128.
   PubMedGoogle Scholar
• Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24:1507–1523.
   PubMed Web of Science ®Google Scholar
• M’Koma AE, Wise PE, Schwartz DA, et al. Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis Colon Rectum. 2009;52:726–739.
   PubMed Web of Science ®Google Scholar
• Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211–222.
   PubMed Web of Science ®Google Scholar
• Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846–53e1–2.
   Web of Science ®Google Scholar
• Gisbert JP, Bermejo F, Pajares R, et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis. 2009;15:1485–1491.
   PubMed Web of Science ®Google Scholar
• Gasche C, Dejaco C, Waldhoer T, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med. 1997;126:782–787.
   PubMed Web of Science ®Google Scholar
• Koutroubakis IE, Karmiris K, Makreas S, et al. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. Eur J Gastroenterol Hepatol. 2006;18:421–425.
   PubMed Web of Science ®Google Scholar
• Endo H, Higurashi T, Hosono K, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterology. 2011;46. 894–905.
   PubMed Web of Science ®Google Scholar
• Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45:S18–21.
   PubMed Web of Science ®Google Scholar
• Koffeman AR, Valkhoff VE, Celik S, et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br J Gen Pract. 2014;64:e191–e198.
   PubMed Web of Science ®Google Scholar
• Davis JS, Lee HY, Kim J, et al. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Heart. 2017;4:e000550.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K. U.S. preventive services task force. aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164:836–845.
   PubMed Web of Science ®Google Scholar
• Garcia-Rayado G, Navarro M, Lanas A. NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Rev Clin Pharmacol. 2018;11:1031–1043.
   PubMed Web of Science ®Google Scholar
• Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633–1641.
   PubMed Web of Science ®Google Scholar
• Lichtenberger LM. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol. 2001;61:631–637.
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Rafi S, Hayllar J, et al. Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine. Gut. 1997;41:344–353.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clinical Gastroenterol Hepatol. 2007;5:1040–1045.
   PubMed Web of Science ®Google Scholar
• Niikura R, Yamada A, Maki K, et al. Associations between drugs and small-bowel mucosal bleeding: multicenter capsule-endoscopy study. Dig Endosc. 2018;30:79–89.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kudo T, Esaki M, et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gatroenterol. 2008;43. 490–496.
   PubMed Web of Science ®Google Scholar
• Han Y, Liao Z, al LY. Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury. J Am Coll Cardiol. 2022;79:116–128. .
   PubMed Web of Science ®Google Scholar
• Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749–754.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clinical Gastroenterol Hepatol. 2005;3:133–141.
   PubMed Web of Science ®Google Scholar
• Tai FWD, McAlindon ME. NSAIDs and the small bowel. Curr Opin Gastroenterol. 2018;34:175–182.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172–1178.
   PubMed Web of Science ®Google Scholar
• Dammann HG, Burkhardt F, Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Aliment Pharmacol Ther. 1999;13:1109–1114.
   PubMed Web of Science ®Google Scholar
• Lanza FL, Royer GL, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med. 1980;303:136–138.
   PubMed Web of Science ®Google Scholar
• Endo H, Hosono K, Inamori M, et al. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol. 2009;44:544–549.
   PubMed Web of Science ®Google Scholar
• Watari I, Oka S, Tanaka S, et al. Comparison of small-bowel mucosal injury between low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs: a capsule endoscopy study. Digestion. 2014;89:225–231.
   PubMed Web of Science ®Google Scholar
• Endo H, Hosono K, Higurashi T, et al. Quantitative analysis of low-dose aspirin-associated small bowel injury using a capsule endoscopy scoring index. Dig Endosc. 2011;23:56–61.
   PubMed Web of Science ®Google Scholar
• Chan FK, Lanas A, Scheiman J, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010;376:173–179.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, De Cruz P. Review article: a practical approach to the clinical management of NSAID enteropathy. Scand J Gastroenterol. 2017;52:941–947.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Goh V, Lima G, et al. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. J Pain Res. 2018;11:361–374.
   PubMed Web of Science ®Google Scholar
• Ota K, Takeuchi T, Kojima Y, et al. Preventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study. BMC Gastroenterol. 2019;19:4.
   PubMed Web of Science ®Google Scholar
• Taha AS, McCloskey C, McSkimming P, et al. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3:469–476.
   PubMed Web of Science ®Google Scholar
• Gordon FH, Watkinson A, Hodgson H. Vascular malformations of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2001;15:41–58.
   PubMed Web of Science ®Google Scholar
• Poralla T. Angiodysplasia in the renal patient: how to diagnose and how to treat? Nephrol Dial Transplant. 1998;13:2188–2191.
   PubMed Web of Science ®Google Scholar
• Cappell MS. Spatial clustering of simultaneous nonhereditary gastrointestinal angiodysplasia. Small but significant correlation between nonhereditary colonic and upper gastrointestinal angiodysplasia. Dig Dis Sci. 1992;37:1072–1077.
   PubMed Web of Science ®Google Scholar
• Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol. 1995;90:564–567.
   PubMed Web of Science ®Google Scholar
• Lecleire S, Iwanicki-Caron I, Di-Fiore A, et al. Yield and impact of emergency capsule enteroscopy in severe obscure-overt gastrointestinal bleeding. Endoscopy. 2012;44:337–342.
   PubMed Web of Science ®Google Scholar
• Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958;259:196.
   Web of Science ®Google Scholar
• Blackshear JL, McRee CW, Safford RE, et al. von Willebrand factor abnormalities and heyde syndrome in dysfunctional heart valve prostheses. JAMA Cardiol. 2016;1:198–204.
   PubMed Web of Science ®Google Scholar
• Sadler JE. Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med. 2003;349:323–325.
   PubMed Web of Science ®Google Scholar
• Tsagianni A, Comer DM, Yabes JG, et al. Von Willebrand disease and gastrointestinal bleeding: a national inpatient sample study. Thromb Res. 2019;178:119–123.
   PubMed Web of Science ®Google Scholar
• Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc. 2014;80:435–46.e1.
   PubMed Web of Science ®Google Scholar
• Jabbar HR, Abbas A, Ahmed M, et al. The incidence, predictors and outcomes of gastrointestinal bleeding in patients with left ventricular assist device (LVAD). Dig Dis Sci. 2015;60:6–3697.
   Web of Science ®Google Scholar
• Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol. 1996;91:2329–2332.
   PubMed Web of Science ®Google Scholar
• Karagiannis S, Goulas S, Kosmadakis G, et al. Wireless capsule endoscopy in the investigation of patients with chronic renal failure and obscure gastrointestinal bleeding (preliminary data). World J Gastroenterol. 2006;12:5182–5185.
   PubMed Web of Science ®Google Scholar
• Mohee K, Aldalati O, Dworakowski R, et al. Aortic stenosis and anemia with an update on approaches to managing angiodysplasia in 2018. Cardiol J. 2020;27:72–77.
   PubMed Web of Science ®Google Scholar
• Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105–109.
   PubMed Web of Science ®Google Scholar
• Boley SJ, Sammartano R, Adams A, et al. On the nature and etiology of vascular ectasias of the colon Degenerative lesions of aging. Gastroenterology. 1977;72:650–660.
   PubMed Web of Science ®Google Scholar
• Bauditz J. Effective treatment of gastrointestinal bleeding with thalidomide–Chances and limitations. World J Gastroenterol. 2016;22:3158–3164.
   PubMed Web of Science ®Google Scholar
• Becq A, Rahmi G, Perrod G, et al. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management. Gastrointest Endosc. 2017;86:792–806.
   PubMed Web of Science ®Google Scholar
• Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:474–483.
   PubMed Web of Science ®Google Scholar
• Walker TG. Acute gastrointestinal hemorrhage. Tech Vasc Interv Radiol. 2009;12:80–91.
   PubMedGoogle Scholar
• Arieira C, Magalhães R, Dias de Castro F, et al. Small bowel angioectasias rebleeding and the identification of higher risk patients. Dig Dis Sci. 2021;66:175–180.
   PubMed Web of Science ®Google Scholar
• Junquera F, Saperas E, Videla S, et al. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol. 2007;102:254–260.
   PubMed Web of Science ®Google Scholar
• Holleran G, Hall B, Breslin N, et al. Long-acting somatostatin analogues provided significant beneficial effect in patients with refractory small bowel angiodysplasia: results from a proof of concept open label mono-centre trial. United European Gastroenterol J. 2016;4:70–76.
   PubMed Web of Science ®Google Scholar
• Goltstein LCMJ, Grooteman KV, Rocco A, et al. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:922–932.
   PubMed Web of Science ®Google Scholar
• Junquera F, Feu F, Papo M, et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology. 2001;121:1073–1079.
   PubMed Web of Science ®Google Scholar
• Patwardhan VR, Cardenas A. Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. Aliment Pharmacol Ther. 2014;40:354–362.
   PubMed Web of Science ®Google Scholar
• Ballester-Clau R, Torres Vicente G, Cucala Ramos M, et al. Efficacy and safety of treatment with ferric carboxymaltose in patients with cirrhosis and gastrointestinal bleeding. Front Med (Lausanne). 2020;7:128.
   PubMed Web of Science ®Google Scholar
• Ubesie AC, Kocoshis SA, Mezoff AG, et al. Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition. J Pediatr. 2013;163:1692–1696.
   PubMed Web of Science ®Google Scholar
• Kubo A, Kagaya T, Nakagawa H. Studies on complications of diverticular disease of the colon. Jpn J Med. 1985;24:39–43.
   PubMedGoogle Scholar
• Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123–130.
   PubMed Web of Science ®Google Scholar
• Ko CW, Siddique SM, Patel A, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159:1085–1094.
   PubMed Web of Science ®Google Scholar
• Richards T, Breymann C, Brookes MJ, et al. Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Ann Med. 2021;53:274–285.
   PubMed Web of Science ®Google Scholar
• WHO. guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020.
   Google Scholar
• Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103:1182–1192.
   PubMed Web of Science ®Google Scholar
• Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44:838–845.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, noninferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877–1888.
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Livraghi A, Aronico N, et al. Impact of in-hospital intravenous iron supplementation on red blood cell transfusions: experience from an internal medicine unit. Blood Transfus. 2021;19:448–455.
   PubMed Web of Science ®Google Scholar
• Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23.
   PubMed Web of Science ®Google Scholar
• Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res. 2013;28:1793–1803.
   PubMed Web of Science ®Google Scholar
• Glaspy JA, Lim-Watson MZ, Libre MA, et al. Hypophosphatemia associated with intravenous iron therapies for iron deficiency anemia: a systematic literature review. Ther Clin Risk Manag. 2020;16:245–259.
   PubMed Web of Science ®Google Scholar
• Bastida G, Herrera-de Guise C, Algaba A, et al. sucrosomial iron supplementation for the treatment of iron deficiency anemia in inflammatory bowel disease patients refractory to oral iron treatment. Nutrients. 2021;13:1770.
   PubMed Web of Science ®Google Scholar
• Giancotti L, Talarico V, Mazza GA, et al. Feralgine™ a new approach for iron deficiency anemia in celiac patients. Nutrients. 2019;11:887.
   PubMed Web of Science ®Google Scholar
• Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med. 1996;334:619–623.
   PubMed Web of Science ®Google Scholar
• Gasche C, Ahmad T, Tulassay Z, et al. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015;21:579–588.
   PubMed Web of Science ®Google Scholar
• Cummings JF, Fraser A, Stansfield C, et al. Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK. BMJ Open Gastroenterology. 2021;8. e000530.
   PubMed Web of Science ®Google Scholar
• Howaldt S, Domènech E, Martinez N, et al. Long-term effectiveness of oral ferric maltol vs intravenous ferric carboxymaltose for the treatment of iron-deficiency anemia in patients with inflammatory bowel disease: a randomized controlled noninferiority trial. Inflamm Bowel Dis. 2022;28:373–384.
   PubMed Web of Science ®Google Scholar
• Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4:e524–e33.
   PubMed Web of Science ®Google Scholar
• Prentice AM, Doherty CP, Abrams SA, et al. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012;119:1922–1928.
   PubMed Web of Science ®Google Scholar
• Miller SD, Cuffari C, Akhuemonkhan E, et al. Anemia screening, prevalence, and treatment in pediatric inflammatory bowel disease in the United States, 2010-2014. Pediatr Gastroenterol Hepatol Nutr. 2019;22:152–161.
   PubMed Web of Science ®Google Scholar
• Patel D, Yang YX, Trivedi C, et al. Incidence, duration, and management of anemia: a nationwide comparison between IBD and non-IBD populations. Inflamm Bowel Dis. 2020;26:934–940.
   PubMed Web of Science ®Google Scholar